Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
May 5, 2025
Transcriptome-wide Mendelian randomisation exploring dynamic CD4+ T cell gene expression in colorectal cancer development
Benedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Cell Metabolism
|
May 25, 2023
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity
Benjamin J Jenkins, Julianna Blagih, Fernando M Ponce-Garcia, et al.
Diabetologia
|
May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
James Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
Elife
|
May 18, 2022
Correction: Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation
Susan Martin, Jessica Tyrrell, E Louise Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 22, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomization
Caroline J Bull, Emma Hazelwood, Joshua A Bell, et al.
BMC Medicine
|
January 4, 2023
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study
Nikos Papadimitriou, Caroline J Bull, Mazda Jenab, et al.
BMC Medicine
|
January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization
Mark Gormley, Tom Dudding, Linda Kachuri, et al.
Journal of the National Cancer Institute
|
January 20, 2022
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis
Neil Murphy, Mingyang Song, Nikos Papadimitriou, et al.
Elife
|
January 25, 2022
Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation
Susan Martin, Jessica Tyrrell, E Louise Thomas, et al.
Journal of the National Cancer Institute
|
June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention
James Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Medrxiv : the Preprint Server for Health Sciences
|
May 5, 2025
Transcriptome-wide Mendelian randomisation exploring dynamic CD4+ T cell gene expression in colorectal cancer development
Benedita Deslandes, Xueyan Wu, Matthew A Lee, et al.
Cell Metabolism
|
May 25, 2023
Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity
Benjamin J Jenkins, Julianna Blagih, Fernando M Ponce-Garcia, et al.
Diabetologia
|
May 12, 2023
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
James Yarmolinsky, Emmanouil Bouras, Andrei Constantinescu, et al.
Elife
|
May 18, 2022
Correction: Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation
Susan Martin, Jessica Tyrrell, E Louise Thomas, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 22, 2023
Identifying metabolic features of colorectal cancer liability using Mendelian randomization
Caroline J Bull, Emma Hazelwood, Joshua A Bell, et al.
BMC Medicine
|
January 4, 2023
Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study
Nikos Papadimitriou, Caroline J Bull, Mazda Jenab, et al.
BMC Medicine
|
January 31, 2022
Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization
Mark Gormley, Tom Dudding, Linda Kachuri, et al.
Journal of the National Cancer Institute
|
January 20, 2022
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis
Neil Murphy, Mingyang Song, Nikos Papadimitriou, et al.
Elife
|
January 25, 2022
Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation
Susan Martin, Jessica Tyrrell, E Louise Thomas, et al.
Journal of the National Cancer Institute
|
June 13, 2025
Proteogenomic and observational evidence implicate ANGPTL4 as a potential therapeutic target for colorectal cancer prevention
James Yarmolinsky, Matthew A Lee, Evelyn Lau, et al.
Page
of 8